Citigroup Has Lowered Expectations for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGL) had its target price lowered by Citigroup from $2.50 to $1.75 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “sell” rating on the stock. Citigroup’s price target suggests a potential upside of 1.74% from the stock’s previous close.

AGL has been the subject of a number of other research reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a report on Wednesday, August 7th. Benchmark reissued a “buy” rating and issued a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. TD Cowen lowered their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday. Barclays cut their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday. Finally, Evercore ISI lowered their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, agilon health currently has a consensus rating of “Hold” and a consensus price target of $6.38.

agilon health Trading Down 8.5 %

NYSE AGL opened at $1.72 on Wednesday. The company has a market capitalization of $708.67 million, a price-to-earnings ratio of -1.83 and a beta of 0.60. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a twelve month low of $1.70 and a twelve month high of $13.76. The stock’s 50-day simple moving average is $3.09 and its two-hundred day simple moving average is $4.88.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the prior year, the firm posted ($0.06) EPS. Research analysts forecast that agilon health will post -0.35 EPS for the current fiscal year.

Insider Buying and Selling at agilon health

In other news, CEO Steven Sell bought 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 42.03 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On agilon health

A number of institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after acquiring an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC increased its position in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares in the last quarter. Capital International Investors lifted its holdings in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. Finally, Simplicity Wealth LLC grew its holdings in shares of agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after buying an additional 15,515 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.